These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8049012

  • 1. Cytotoxic activity of some gold(III) complexes.
    Cossu F, Matovic Z, Radanovic D, Ponticelli G.
    Farmaco; 1994 Apr; 49(4):301-2. PubMed ID: 8049012
    [Abstract] [Full Text] [Related]

  • 2. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L, Giovagnini L, Marzano C, Bettìo F, Graziani R, Pilloni G, Fregona D.
    Inorg Chem; 2005 Mar 21; 44(6):1867-81. PubMed ID: 15762713
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
    Calamai P, Carotti S, Guerri A, Mazzei T, Messori L, Mini E, Orioli P, Speroni GP.
    Anticancer Drug Des; 1998 Jan 21; 13(1):67-80. PubMed ID: 9474243
    [Abstract] [Full Text] [Related]

  • 4. Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes.
    Buckley RG, Elsome AM, Fricker SP, Henderson GR, Theobald BR, Parish RV, Howe BP, Kelland LR.
    J Med Chem; 1996 Dec 20; 39(26):5208-14. PubMed ID: 8978849
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic activity of [Pt(pyr)(N-Etlm)Cl4].
    Massacesi M, Matovic Z, Ponticelli G.
    Farmaco; 1993 Sep 20; 48(9):1327-30. PubMed ID: 8259989
    [Abstract] [Full Text] [Related]

  • 6. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC, Bacac M, Velders AH, Jansen BA, Kooijman H, Spek AL, Haasnoot JG, Reedijk J.
    J Med Chem; 2003 Apr 24; 46(9):1743-50. PubMed ID: 12699392
    [Abstract] [Full Text] [Related]

  • 7. Gold(III) complexes as a new family of cytotoxic and antitumor agents.
    Marcon G, Messori L, Orioli P.
    Expert Rev Anticancer Ther; 2002 Jun 24; 2(3):337-46. PubMed ID: 12113057
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C, Pellei M, Colavito D, Alidori S, Lobbia GG, Gandin V, Tisato F, Santini C.
    J Med Chem; 2006 Dec 14; 49(25):7317-24. PubMed ID: 17149861
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
    Habtemariam A, Melchart M, Fernandez R, Parsons S, Oswald ID, Parkin A, Fabbiani FP, Davidson JE, Dawson A, Aird RE, Jodrell DI, Sadler PJ.
    J Med Chem; 2006 Nov 16; 49(23):6858-68. PubMed ID: 17154516
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K.
    Biol Chem; 1999 Nov 16; 380(11):1287-94. PubMed ID: 10614821
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells.
    Yan YK, Cho SE, Shaffer KA, Rowell JE, Barnes BJ, Hall IH.
    Pharmazie; 2000 Apr 16; 55(4):307-13. PubMed ID: 10798247
    [Abstract] [Full Text] [Related]

  • 12. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 13. Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds.
    Messori L, Abbate F, Marcon G, Orioli P, Fontani M, Mini E, Mazzei T, Carotti S, O'Connell T, Zanello P.
    J Med Chem; 2000 Sep 21; 43(19):3541-8. PubMed ID: 11000008
    [Abstract] [Full Text] [Related]

  • 14. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ, Mirabelli CK, Johnson RK, Mattern MR, McCabe FL, Faucette LF, Sung CM, Mong SM, Sadler PJ, Crooke ST.
    Cancer Res; 1986 Nov 21; 46(11):5486-93. PubMed ID: 3756897
    [Abstract] [Full Text] [Related]

  • 15. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A, Gamboa G, Nasseri A, Podnos YD, Emma D, Dorion G, Rawlings L, Carpenter PM, Bustamante A, Patel J, Rideout D.
    Gynecol Oncol; 1996 Feb 21; 60(2):203-12. PubMed ID: 8631539
    [Abstract] [Full Text] [Related]

  • 16. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM, Orr RM, Valenti MR, Barnard CF, Murrer BA, Kelland LR, Harrap KR.
    Anticancer Res; 1996 Feb 21; 16(1):33-8. PubMed ID: 8615631
    [Abstract] [Full Text] [Related]

  • 17. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
    Bratsos I, Jedner S, Bergamo A, Sava G, Gianferrara T, Zangrando E, Alessio E.
    J Inorg Biochem; 2008 Feb 21; 102(5-6):1120-33. PubMed ID: 18279961
    [Abstract] [Full Text] [Related]

  • 18. Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study.
    Castiñeiras A, Dehnen S, Fuchs A, García-Santos I, Sevillano P.
    Dalton Trans; 2009 Apr 21; (15):2731-9. PubMed ID: 19333496
    [Abstract] [Full Text] [Related]

  • 19. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
    Najajreh Y, Khazanov E, Jawbry S, Ardeli-Tzaraf Y, Perez JM, Kasparkova J, Brabec V, Barenholz Y, Gibson D.
    J Med Chem; 2006 Jul 27; 49(15):4665-73. PubMed ID: 16854072
    [Abstract] [Full Text] [Related]

  • 20. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J.
    J Med Chem; 2003 Mar 27; 46(7):1210-9. PubMed ID: 12646031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.